Literature DB >> 16009768

Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series.

Thomas W Leung1, Ka Sing Wong, Andrew C Hui, Ka Fai To, Sik To Lai, Wai Fu Ng, Ho Keung Ng.   

Abstract

BACKGROUND: The March 2003 outbreak of the severe acute respiratory syndrome (SARS) resulted in significant morbidity and mortality. Muscle weakness and elevated serum creatine kinase levels are commonly encountered in patients with SARS. However, the nature and cause of myopathy associated with a SARS infection are unknown because, to our knowledge, there has been no report of histological or postmortem examination of the skeletal muscle from SARS-infected patients.
OBJECTIVE: To determine the exact nature of the myopathy associated with SARS.
METHOD: Postmortem skeletal muscles from 8 consecutive patients who died of SARS in March 2003 were studied under light and electron microscopy as well as immunohistochemistry.
RESULTS: Focal myofiber necrosis was identified in 4 of 8 cases. Macrophage infiltration and regenerative fiber were scanty. All 4 patients treated with a steroid had significant myofiber atrophy. In situ hybridization for coronavirus was negative in all subjects. Viral cultures for coronavirus and examination for viral particles under electron microscopy were performed in 2 patients. The viral culture yielded no organisms and there were no viral particles seen on electron microscopic examination.
CONCLUSIONS: There is a spectrum of myopathic changes associated with a SARS infection. Focal myofiber necrosis is common and possibly is immune mediated. Critical illness myopathy and superimposed steroid myopathy may also play an important role in SARS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009768     DOI: 10.1001/archneur.62.7.1113

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  49 in total

Review 1.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 2.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

Review 3.  COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.

Authors:  Tanveer Ahmad; Rituparna Chaudhuri; Mohan C Joshi; Ahmad Almatroudi; Arshad Husain Rahmani; Syed Mansoor Ali
Journal:  Front Microbiol       Date:  2020-12-01       Impact factor: 5.640

4.  Neuromusculoskeletal disorders following SARS: a case series.

Authors:  Brynne Stainsby; Scott Howitt; Jason Porr
Journal:  J Can Chiropr Assoc       Date:  2011-03

Review 5.  [Critical illness myopathy in intensive care patients. Pathogenetic concepts and clinical management].

Authors:  O Friedrich; E Hund
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

Review 6.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 7.  [Critical illness polyneuropathy and myopathy as neurological complications of sepsis].

Authors:  R Kollmar
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

8.  Myopathic changes in patients with long-term fatigue after COVID-19.

Authors:  J Agergaard; S Leth; T H Pedersen; T Harbo; J U Blicher; P Karlsson; L Østergaard; H Andersen; H Tankisi
Journal:  Clin Neurophysiol       Date:  2021-05-07       Impact factor: 3.708

9.  Severe loss of mechanical efficiency in COVID-19 patients.

Authors:  Eulogio Pleguezuelos; Amin Del Carmen; Gemma Llorensi; Jessica Carcole; Paula Casarramona; Eva Moreno; Pilar Ortega; Mateo Serra-Prat; Elisabet Palomera; Marc M Miravitlles; Joan Carles Yebenes; Ramón Boixeda; Lluis Campins; Koldo Villelabeitia-Jaureguizar; Manuel Vicente Garnacho-Castaño
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-06-08       Impact factor: 12.063

10.  Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.

Authors:  Carlos Manuel Romero-Sánchez; Inmaculada Díaz-Maroto; Eva Fernández-Díaz; Álvaro Sánchez-Larsen; Almudena Layos-Romero; Jorge García-García; Esther González; Inmaculada Redondo-Peñas; Ana Belén Perona-Moratalla; José Antonio Del Valle-Pérez; Julia Gracia-Gil; Laura Rojas-Bartolomé; Inmaculada Feria-Vilar; María Monteagudo; María Palao; Elena Palazón-García; Cristian Alcahut-Rodríguez; David Sopelana-Garay; Yóscar Moreno; Javaad Ahmad; Tomás Segura
Journal:  Neurology       Date:  2020-06-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.